Literature DB >> 13129771

Propagation of archetype and nonarchetype JC virus variants in human fetal brain cultures: demonstration of interference activity by archetype JC virus.

Frank J O'Neill1, John E Greenlee, Kristina Dörries, Susan A Clawson, Helen Carney.   

Abstract

In immunologically normal individuals, the polyomavirus, JC virus (JCV), produces an asymptomatic primary infection followed by lifelong persistence of the virus in renal tubular epithelial cells. In some immunocompromised patients, however, in particular acquired immunodeficiency syndrome (AIDS) patients, JCV causes an opportunistic central nervous system (CNS) disorder, progressive multifocal leukoencephalopathy (PML). JCV DNA as it persists in kidneys (archetypal JCV) and JCV DNA isolated from PML lesions show differences in their regulatory regions in which transcription and replication are controlled. Archetypal JCV DNA has a single enhancer and no rearrangements or deletions in the regulatory region. In contrast, JCV DNA from PML isolates is characterized by alterations in the regulatory region. Some PML-associated JCVs can be grown in cultures of human fetal brain (HFB) cells. Growth of archetypal JCV in cultured cells has not been reported, however. Here we demonstrate successful propagation of the archetypal JCV, strain GS/K, in HFB cells. Growth occurred more slowly and to lower titers than is seen with the prototypical PML JCV strain Mad-1, with relatively few cells containing viral T antigen (T-Ag) or viral capsid protein, Vp1. Interestingly, GS/K growth could be enhanced, with a large increase in viral DNA and cytopathic effect, by coinfection with GS/B, a nonarchetypal brain-derived JCV variant isolated from the same PML patient as GS/K. The amount of GS/K DNA was also greatly enhanced when it was cotransfected with Mad-1 JCV DNA, the prototypical PML isolate. In contrast to GS/K plus GS/B-cotransfected cells, in GS/K plus Mad-1-infected cells, cytopathic effect was not increased. On subsequent passage of culture lysates to naïve cells, however, the infection produced by either combination of viral DNAs slowed, no cytopathic effect (CPE) was present, and the amount of GS/B or Mad-1 viral DNA was greatly reduced as compared to that of GS/K DNA. These data suggest that GS/K was able to use either GS/B or Mad-1 as a helper and that GS/K was in turn able to interfere with the growth of either helper virus. Archetype JCV can be successfully propagated in HFB cells, although infection develops much more slowly than that caused by the PML JCV variant Mad-1. The ability of archetypal and variant JCVs to enhance or retard each other's replication may have implications in vivo for the maintenance of JCV persistence and the growth of JCV variants.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 13129771     DOI: 10.1080/13550280390241223

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  30 in total

1.  DNA sequences outside the simian virus 40 early region cause downregulation of T-antigen production in permissive simian cells.

Authors:  F J O'Neill; H Carney; Y Hu; T Chen
Journal:  Virology       Date:  1998-06-05       Impact factor: 3.616

2.  Genome maps of simian virus 40 defectives propagated in human glioblastoma cells.

Authors:  D Carroll; F J O'Neill
Journal:  Virology       Date:  1978-06-01       Impact factor: 3.616

3.  Appearance of defective simian virus 40 following infection of cultured human glioblastoma cells.

Authors:  F J O'Neill; D Carroll
Journal:  Virology       Date:  1978-06-01       Impact factor: 3.616

4.  Human polyomavirus JC control region variants in persistently infected CNS and kidney tissue.

Authors:  C Elsner; K Dörries
Journal:  J Gen Virol       Date:  1998-04       Impact factor: 3.891

Review 5.  Association of papova-virions with a human demyelinating disease (progressive multifocal leukoencephalopathy).

Authors:  G M Zu Rhein
Journal:  Prog Med Virol       Date:  1969

6.  Isolation and characterization of defective simian virus 40 genomes which complement for infectivity.

Authors:  F J O'Neill; E B Maryon; D Carroll
Journal:  J Virol       Date:  1982-07       Impact factor: 5.103

7.  Rearrangements of archetypal regulatory regions in JC virus genomes from urine.

Authors:  H T Agostini; C F Ryschkewitsch; G L Stoner
Journal:  Res Virol       Date:  1998 May-Jun

8.  Human polyomavirus JC promoter/enhancer rearrangement patterns from progressive multifocal leukoencephalopathy brain are unique derivatives of a single archetypal structure.

Authors:  G S Ault; G L Stoner
Journal:  J Gen Virol       Date:  1993-08       Impact factor: 3.891

9.  DNA rearrangements in organ-specific variants of polyomavirus JC strain GS.

Authors:  G Loeber; K Dörries
Journal:  J Virol       Date:  1988-05       Impact factor: 5.103

10.  Persistence of archetypal JC virus DNA in normal renal tissue derived from tumor-bearing patients.

Authors:  T Tominaga; Y Yogo; T Kitamura; Y Aso
Journal:  Virology       Date:  1992-02       Impact factor: 3.616

View more
  1 in total

Review 1.  Progressive multifocal leukoencephalopathy: current treatment options and future perspectives.

Authors:  Dejan Pavlovic; Andriani C Patera; Fredrik Nyberg; Marianne Gerber; Maggie Liu
Journal:  Ther Adv Neurol Disord       Date:  2015-11       Impact factor: 6.570

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.